DNA
Ginkgo Bioworks Holdings, Inc.
NYSE · Healthcare · Biotechnology · US
$6.95
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.11x
- Price / sales
- 4.18x
- Price / cash flow
- -2.75x
Enterprise value
- Enterprise value
- $570.0M
- EV / sales
- 5.10x
- EV / EBITDA
- -2.73x
- EV / EBIT
- -1.96x
- Market cap
- $468.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026